„Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway“. Nigerian Journal of Physiological Sciences, let. 40, št. 2, april 2026, https://doi.org/10.54548/.